Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05689385
Other study ID # 202207060RINC
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date April 20, 2023
Est. completion date December 2024

Study information

Verified date December 2022
Source National Taiwan University Hospital
Contact Hung-Jui Chuang, MD
Phone 00886-2-23123456
Email 103311@ntuh.gov.tw
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this randomized controlled trial is to compare the effect of eHealth-based cardiac rehabilitation with the effect of usual care on exercise capacity and qualify of life in patients after myocardial infarction.


Description:

Cardiac rehabilitation can improve exercise capacity, life of quality, readmission rate and mortality rate for patients after myocardial infarction. International guidelines list cardiac rehabilitation after myocardial infarction as class IA recommendation. However, low participation rate of cardiac rehabilitation due to barriers such as lacking of time, transport or affordability issues is an unsolved problem worldwide. eHealth, consisting of telemedicine, mobile health and personalized care using wearable devices has the potential to remove the barriers and become an effective model to deliver cardiac rehabilitation. Thus, we design a randomized controlled trial to compare the effect of a case manager-led eHealth-based cardiac rehabilitation program with usual care on the compliance, physical activity, quality of life, and cardiorespiratory fitness in patients after myocardial infarction.


Recruitment information / eligibility

Status Recruiting
Enrollment 150
Est. completion date December 2024
Est. primary completion date December 2024
Accepts healthy volunteers No
Gender All
Age group 20 Years and older
Eligibility Inclusion criteria: 1. = 20 years of age. 2. Within 6 months after the onset of acute myocardial infarction. 3. At lowest to moderate risk according to the guideline from American Association of Cardiovascular and Pulmonary Rehabilitation. 4. Unable or refused to attend center-based cardiac rehabilitation. Exclusion criteria: 1. Unable to walk independently or use a stationary bike. 2. Unable to follow verbal command. 3. Not having a smartphone which can get on the internet. 4. Having contraindications for exercise according to American College of Sports Medicine's Guidelines for Exercise Testing and Prescription. 5. Unable to provide informed consent.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
eHealth-based cardiac rehabilitation
The 12-wk case manager-led eHCR program includes: Individualized exercise prescription according to the results of cardiopulmonary exercise test. At least one session of in-person physical therapy to familiarize participants with the process of exercise training before the initiation of telerehabilitation. Telerehabilitation: a 30-minute moderate aerobic exercise training with remote monitoring and instruction using video conferencing. (Frequency: twice per week in the first 4 weeks, once per week in the 5th-8th week, once every 2 weeks in the 9th-12th week) Additional self-exercise to achieve the target volume of 150-minute moderate aerobic exercise and 2 sessions of resistance training per week. Patient education for secondary prevention delivered regularly via a communication app on the smartphone. Weekly follow-up call from a case manager via phone call or communication app.

Locations

Country Name City State
Taiwan National Taiwan University Hospital Taipei

Sponsors (1)

Lead Sponsor Collaborator
National Taiwan University Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change of peak oxygen uptake Peak oxygen uptake will be assessed using cardiopulmonary exercise test before intervention, at 12 weeks (post-intervention), and at 12 months. at baseline, 12 weeks(post-intervention), and 12 months.
Primary Change of ventilatory anaerobic threshold Ventilatory anaerobic threshold will be assessed using cardiopulmonary exercise test before intervention, at 12 weeks (post-intervention), and at 12 months. at baseline, 12 weeks(post-intervention), and 12 months.
Secondary Adherence to prescribed exercise The degree of completion of prescribed exercise will be assessed at 12 weeks and 12 months. at 12 weeks(post-intervention) and 12 months.
Secondary Evaluation of Quality of life The investigators will assess the change in 36-Item Short Form Survey(SF-36). at baseline, 12 weeks(post-intervention), and 12 months.
Secondary Depression The investigators will assess the change in Patient Health Questionnaire (PHQ-9). The PHQ-9 score ranges from 0-27. Higher scores indicate worsen symptoms. at baseline, 12 weeks(post-intervention), and 12 months.
Secondary Anxiety The investigators will assess the change in Generalized Anxiety Disorder scale (GAD-7). The GAD-7 score ranges 0-21. Higher scores indicate worsen symptoms. at baseline, 12 weeks(post-intervention), and 12 months.
Secondary Evaluation of physical activity The investigators will assess the change in physical activity using Long form International Physical Activity Questionnaire(IPAQ) Taiwan version. at baseline, 12 weeks(post-intervention), and 12 months.
Secondary Evaluation of grip strength The grip strength will be measured using a grip goniometer with the participants seated and the elbow flexed at 90 degrees. at baseline, 12 weeks(post-intervention), and 12 months.
Secondary Evaluation of isometric knee extension strength The isometric knee extension strength will be measured using a dynamometer with participants seated and knee flexed at 90 degrees. at baseline, 12 weeks(post-intervention), and 12 months.
See also
  Status Clinical Trial Phase
Recruiting NCT06013813 - Conventional vs. Distal Radial Access Outcomes in STEMI Patients Treated by PCI N/A
Completed NCT04507529 - Peer-mentor Support for Older Vulnerable Myocardial Infarction Patients N/A
Recruiting NCT06066970 - Cardiac Biomarkers for the Quantification of Myocardial Damage After Cardiac Surgery
Recruiting NCT03620266 - Effects of Bilberry and Oat Intake After Type 2 Diabetes and/or MI N/A
Completed NCT04097912 - Study to Gather Information to What Extent Patients Follow the Treatment Regimen of Low-dose Aspirin for Primary and Secondary Prevention of Diseases of the Heart and Blood Vessels
Completed NCT04153006 - Comparison of Fingerstick Versus Venous Sample for Troponin I.
Completed NCT03668587 - Feasibility and Security of a Rapid Rule-out and rule-in Troponin Protocol in the Management of NSTEMI in an Emergency Departement
Recruiting NCT01218776 - International Survey of Acute Coronary Syndromes in Transitional Countries
Completed NCT03076801 - Does Choral Singing Help imprOve Stress in Patients With Ischemic HeaRt Disease? N/A
Recruiting NCT05371470 - Voice Analysis Technology to Detect and Manage Depression and Anxiety in Cardiac Rehabilitation N/A
Recruiting NCT04562272 - Attenuation of Post-infarct LV Remodeling by Mechanical Unloading Using Impella-CP N/A
Completed NCT04584645 - A Digital Flu Intervention for People With Cardiovascular Conditions N/A
Active, not recruiting NCT04475380 - Complex All-comers and Patients With Diabetes or Prediabetes, Treated With Xience Sierra Everolimus-eluting Stents
Not yet recruiting NCT06007950 - Time-restricted Eating Study (TRES): Impacts on Anthropometric, Cardiometabolic and Cardiovascular Health N/A
Withdrawn NCT05327855 - Efficacy and Safety of OPL-0301 Compared to Placebo in Adults With Post-Myocardial Infarction (MI) Phase 2
Recruiting NCT02876952 - High Intensity Aerobic Interval Training With Mediterranean Diet Recommendations in Post-Myocardial Infarct Patients N/A
Completed NCT02917213 - Imaging Silent Brain Infarct And Thrombosis in Acute Myocardial Infarction
Completed NCT02711631 - Feasibility and Effectiveness of Remote Virtual Reality-Based Cardiac Rehabilitation N/A
Completed NCT02305602 - A Study of VentriGel in Post-MI Patients Phase 1
Completed NCT02382731 - Interventions to Support Long-Term Adherence aNd Decrease Cardiovascular Events Post-Myocardial Infarction N/A